The medication slows gastric emptying, which can cause nausea, bloating, or vomiting when high-sugar foods are consumed, particularly during dose escalation
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirz, Volume 110 Issue 1, De Block, C., Bailey, C., Wysham, C., Hemmingway, A., Allen, S
Indeed, alterations of the ANS might be involved in the pathogenesis of obesity, acting on different pathways
Kullanm talimatlarna ve nerilen dozlara dikkat edilmesi, olas Glutatyon yan etkileri ni en aza indirmek iin kritik nem tamaktadr
It also functions as a precursor to glutathione peroxidase, a key antioxidant enzyme, which protects against lipid peroxidation (
GIP has been shown to decrease appetite and increase energy expenditure, which leads to weight loss